Latest DEF 14A proxy statements

Usio, Inc. has issued its definitive proxy statement for the 2026 Annual Stockholder Meeting, scheduled for June 10, 2026, detailing proposals for director elections, executive compensation, and auditor ratification.

ARS Pharmaceuticals announces its 2026 Annual Meeting of Stockholders, scheduled for June 24, 2026, and provides an update on the successful commercial launch of its needle-free epinephrine nasal spray, neffy.

LanzaTech Global announces its 2026 Annual Meeting of Stockholders, detailing director elections, auditor ratification, and executive compensation.

AbCellera Biologics Inc. has announced its 2026 Annual Meeting of Shareholders will be held virtually on June 11, 2026, to elect directors, ratify auditor appointment, and vote on executive compensation.

Terex Corporation has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 25, 2026, detailing director nominations, executive compensation, and incentive plans.

Solitario Resources Corp. has issued a proxy statement detailing its upcoming Annual Meeting of Shareholders on June 17, 2026, focusing on director elections, executive compensation, and auditor ratification.

Hawaiian Electric Industries (HEI) announced its 2026 Annual Meeting of Shareholders, to be held virtually on June 11, 2026, detailing director nominations and executive compensation.

HCW Biologics Inc. is holding its 2026 Annual Meeting of Stockholders on June 15, 2026, to vote on director elections, auditor ratification, a reverse stock split, and warrant proposals.

OFS Capital Corporation is holding a special meeting on June 10, 2026, to seek stockholder approval for a proposal allowing the company to issue shares of its common stock at a price below its net asset value (NAV) under certain conditions.

Titan Machinery Inc. announces its 2026 Annual Meeting of Stockholders to be held virtually on June 8, 2026, with key proposals including director elections and executive compensation.

Evolus, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 11, 2026, to be held virtually via live webcast.

Arvinas, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 24, 2026, to elect directors, vote on executive compensation, and ratify auditor appointment.

Datadog, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 15, 2026, detailing proposals for director elections, executive compensation, auditor ratification, and a stockholder proposal.

OFS Capital Corporation has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 10, 2026, detailing proposals for director elections and auditor ratification.

International Seaways, Inc. has announced its Annual Meeting of Stockholders will be held on June 8, 2026, with a hybrid in-person and virtual format.

Heartflow, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 16, 2026, to elect directors and ratify the appointment of its independent auditor.

John Marshall Bancorp, Inc. has issued its proxy statement for the 2026 Annual Meeting of Shareholders, scheduled for June 16, 2026, detailing proposals for director elections and auditor ratification.

Shoulder Innovations, Inc. invites stockholders to its 2026 Annual Meeting on June 26, 2026, to elect directors and ratify auditor appointment.

Citizens Community Bancorp, Inc. has announced its 2026 Annual Meeting of Stockholders, set for June 16, 2026, to elect directors, approve an incentive plan, and ratify auditor appointments.

LivaNova PLC has announced its 2026 Annual General Meeting of Shareholders, scheduled for June 10, 2026, to elect directors, approve executive compensation, and ratify auditor appointments.

Encore Capital Group, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 12, 2026, to elect directors, approve executive compensation, and ratify auditor appointments.

Compass Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 10, 2026, with a record date of April 15, 2026.

Titan International, Inc. has filed its 2026 Proxy Statement detailing the upcoming Annual Meeting of Stockholders on June 18, 2026, focusing on director elections, auditor ratification, and executive compensation.

Fortive Corporation announced its 2026 Annual Meeting of Shareholders, scheduled for June 9th, with proposals including director elections, executive compensation advisory vote, and auditor ratification.

Genelux Corporation has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 16, 2026, to elect a director and ratify auditor.

Centessa Pharmaceuticals PLC has issued a proxy statement for its 2026 Annual General Meeting, scheduled for June 12, 2026, detailing proposals for director re-appointments, auditor ratification, and adoption of financial reports.

Celldex Therapeutics announces its 2026 Annual Meeting of Stockholders, scheduled for June 25, 2026, to elect directors, ratify auditors, and approve equity plan amendments.

Marblegate Capital Corporation has issued a proxy statement detailing the agenda for its 2026 Annual Meeting of Stockholders, including director elections and equity plan adoption.

Legence Corp. has announced its 2026 Annual Meeting of Stockholders, highlighting a strong 2025 performance post-IPO and a positive outlook for the upcoming year.

908 Devices Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 11, 2026, to be held virtually.